Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-06-06 @ 8:15 PM
Study NCT ID:
NCT05966467
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2023-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D9282C00003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None